Helen C. Adams serves as Executive at Prometheus Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Helen C. Adams has executed 6 insider transactions totaling $48.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 20, 2024 involved receiving (via award) 74,241 shares valued at $0.
Helen C. Adams currently holds 174,754 shares of Prometheus Biosciences, Inc. (RXDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Helen C. Adams has been a net buyer of RXDX stock. They have purchased $48.0K and sold $0 worth of shares.
Helen C. Adams's most recent insider trade was on May 20, 2024, when they sold 74,241 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 12, 2023 | IMMX | $38.5K | Purchase | 13,000 | $2.96 | Discretionary |
| Jun 16, 2023 | RXDX | $0 | Disposition | 2,674 | $N/A | Discretionary |
| May 19, 2023 | RXDX | $0 | Award | 2,174 | $N/A | Discretionary |
| Mar 16, 2021 | RXDX | $9.5K | Purchase | 500 | $19.00 | Discretionary |